SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Alimera Sciences, Inc. Buyout
Wilmington, Delaware--(Newsfile Corp. - June 27, 2024) - Rigrodsky Law, P.A. is investigating Alimera Sciences, Inc. ("Alimera") (NASDAQ: ALIM) regarding possible breaches of fiduciary duties and othe
Alliance Global Partners Downgrades Alimera Sciences to Neutral From Buy, Adjusts Price Target to $5.50 From $8
12:01 PM EDT, 06/25/2024 (MT Newswires) -- Alliance Global Partners Downgrades Alimera Sciences to Neutral From Buy, Adjusts Price Target to $5.50 From $8 Price: 5.52, Change: -0.02, Percent Change: -
Express News | Alimera Sciences Inc : Alliance Global Partners Cuts to Neutral From Buy
Craig-Hallum Upgrades Alimera Sciences(ALIM.US) to Buy Rating, Raises Target Price to $8
Craig-Hallum analyst Chase Knickerbocker upgrades $Alimera Sciences(ALIM.US)$ to a buy rating, and adjusts the target price from $5.5 to $8.According to TipRanks data, the analyst has a success rate o
Maxim Group Downgrades Alimera Sciences(ALIM.US) to Hold Rating
Maxim Group analyst Naz Rahman downgrades $Alimera Sciences(ALIM.US)$ to a hold rating.According to TipRanks data, the analyst has a success rate of 27.7% and a total average return of -15.8% over the
Express News | Alimera Sciences Inc : Maxim Group Cuts to Hold From Buy
Alimera Sciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/25/2024 8.5% HC Wainwright & Co. → $6 Downgrades Buy → Neutral 05/16/2024 8.5% HC Wainwright & Co. $6 →
Express News | Alimera Sciences Inc : H.c. Wainwright Cuts to Neutral From Buy
H.C. Wainwright Downgrades Alimera Sciences(ALIM.US) to Hold Rating, Maintains Target Price $6
H.C. Wainwright analyst Yi Chen downgrades $Alimera Sciences(ALIM.US)$ to a hold rating, and maintains the target price at $6.According to TipRanks data, the analyst has a success rate of 24.7% and a
Nasdaq Records Worst Session Since April With Nvidia Plunging 7%: Dow Jones Sees Modest Gains Amid Mixed Market Close
The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the "Fear" zone on Monday.U.S. stocks closed mixed on Monday, with the Dow Jones
Express News | Alimera Sciences Inc : Craig-Hallum Cuts to Hold From Buy; Cuts Target Price to $5.50 From $8
Craig-Hallum Downgrades Alimera Sciences(ALIM.US) to Hold Rating, Announces Target Price $5.5
Craig-Hallum analyst Chase Knickerbocker downgrades $Alimera Sciences(ALIM.US)$ to a hold rating, and sets the target price at $5.5.According to TipRanks data, the analyst has a success rate of 44.4%
Trending Stocks Today: Agrify Shoots up 96.92%
June 24th - US stocks trending in regular trading hours.Gainers: $Agrify(AGFY.US)$ shoots up 96.92% to $0.5 with a turnover of $157.71 million. $MicroAlgo(MLGO.US)$ surges 112.43% to $8.2 with a turno
Alimera Sciences Shares Rally Almost 80% After Buyout Offer from ANI Pharmaceuticals
Alimera Sciences shares jumped after the company received a buyout offer of $5.50 a share from ANI Pharmaceuticals.
Dow Jumps 300 Points; Alimera Sciences Shares Spike Higher
U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining more than 300 points on Monday.The Dow traded up 0.80% to 39,463.48 while the NASDAQ fell 0.42% to 17,614.80. The S&P
Shareholder Alert: Ademi LLP Investigates Whether Alimera Sciences, Inc. Has Obtained a Fair Price for Its Public Shareholders
MILWAUKEE, June 24, 2024 /PRNewswire/ -- Ademi LLP is investigating Alimera (Nasdaq: ALIM) for possible breaches of fiduciary duty and other violations of law in its transaction with ANI Pharmaceutic
Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal
On Monday, ANI Pharmaceuticals Inc (NASDAQ:ANIP) agreed to acquire Alimera Sciences Inc (NASDAQ:ALIM) for $5.50 per share in cash and one non-tradable contingent value right (CVR) of up to $0.50 per s
Express News | Alimera Sciences Shares Hit Over 1-1/2 Year High After ANI Pharmaceuticals to Buy Co for $5.5/Shr, Last up 76.8%
Sector Update: Health Care Stocks Advance Premarket Monday
Health care stocks were advancing premarket Monday as the iShares Biotechnology ETF (IBB) was 1.3% higher and the Health Care Select Sector SPDR Fund (XLV) was up 0.3% recently. Alimera Sciences (ALIM
Sector Update: Health Care
Health care stocks were higher premarket Monday as the iShares Biotechnology ETF (IBB) added 1.5% and the Health Care Select Sector SPDR Fund (XLV) was up 0.1% recently. Alimera Sciences (ALIM) shares